Dashboard
Manage Tickers

RNAAvidity Biosciences, Inc.

Nasdaq aviditybiosciences.com


$ 39.67 $ -0.32 (-0.8 %)    

Friday, 14-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 39.64
$ 39.82
$ 0.00 x 0
$ 0.00 x 0
$ 38.85 - $ 41.98
$ 4.83 - $ 42.00
4,730,728
na
3.46B
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-15-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

adobe-avidity-biosciences-and-3-stocks-to-watch-heading-into-friday
Adobe, Avidity Biosciences And 3 Stocks To...
06/14/2024 10:08:09

reported-earlier-avidity-biosciences-prices-4009m-public-offering-of-1055m-common-shares-at-38share
Reported Earlier, Avidity Biosciences Pric...
06/14/2024 06:38:19

All of the shares to be sold in the offering are to be sold by Avidity. The gross proceeds to Avidity from the offering, before...

b-of-a-securities-maintains-buy-on-avidity-biosciences-raises-price-target-to-45
B of A Securities Maintains Buy on Avidity...
06/13/2024 16:08:41

B of A Securities analyst Geoff Meacham maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target fr...

avidity-bioscience-announces-proposed-public-offering-of-300m-of-common-stock
Avidity Bioscience Announces Proposed Publ...
06/12/2024 20:01:45

needham-maintains-buy-on-avidity-biosciences-raises-price-target-to-46
Needham Maintains Buy on Avidity Bioscienc...
06/12/2024 19:35:59

Needham analyst Joseph Stringer maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target from $35 t...

crude-oil-moves-higher-vera-bradley-shares-slide
Crude Oil Moves Higher; Vera Bradley Share...
06/12/2024 18:38:59

chardan-capital-maintains-buy-on-avidity-biosciences-raises-price-target-to-45
Chardan Capital Maintains Buy on Avidity B...
06/12/2024 18:08:32

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and raises the price target from $3...

evercore-isi-group-maintains-outperform-on-avidity-biosciences-raises-price-target-to-45
Evercore ISI Group Maintains Outperform on...
06/12/2024 17:52:05

Evercore ISI Group analyst Josh Schimmer maintains Avidity Biosciences (NASDAQ:RNA) with a Outperform and raises the price t...

why-streamline-health-solutions-shares-are-trading-lower-by-23-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Streamline Health Solutions Shares Are...
06/12/2024 17:25:48

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 16:31:05

nasdaq-jumps-300-points-oracle-shares-spike-higher
Nasdaq Jumps 300 Points; Oracle Shares Spi...
06/12/2024 16:06:12

why-avidity-biosciences-shares-are-trading-higher-wednesday
Why Avidity Biosciences Shares Are Trading...
06/12/2024 15:15:22

The 39 patient trial was in relation to treating facioscapulohumeral muscular dystrophy (FSHD) with delpacibart braxlosiran.

caseys-reports-upbeat-earnings-joins-avidity-biosciences-rentokil-initial-and-other-big-stocks-moving-higher-on-wednesday
Casey's Reports Upbeat Earnings, Joins Avi...
06/12/2024 14:15:52

Core News & Articles
Market-Moving News for June 12th
06/12/2024 12:49:59

BMR: 56% | Beamr Says Its Cloud Solution Is Now Available In The Oracle Cloud Marketplace; Provides AI-Ready Video Processing S...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 12:06:20

avidity-reports-over-50-reduction-in-dux4-regulated-genes-in-phase-12-fortitude-trial-for-facioscapulohumeral-muscular-dystrophy
Avidity Reports Over 50% Reduction In DUX4...
06/12/2024 11:13:37

Avidity plans to accelerate the initiation of registrational cohorts in FORTITUDE™ trial Delpacibart braxlosiran (AOC 1020),...

a-glimpse-into-the-expert-outlook-on-avidity-biosciences-through-6-analysts
A Glimpse Into The Expert Outlook On Avidi...
06/10/2024 12:01:21

needham-reiterates-buy-on-avidity-biosciences-maintains-35-price-target
Needham Reiterates Buy on Avidity Bioscien...
06/10/2024 10:59:25

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

avidity-biosciences-to-present-preliminary-data-from-phase-12-fortitude-trial-of-aoc-1020-in-people-living-with-facioscapulohumeral-muscular-dystrophy-at-the-31st-annual-fshd-society-international-research-congress
Avidity Biosciences To Present Preliminary...
05/29/2024 20:30:04

Jeffrey M. Statland, M.D., Professor of Neurology, University of Kansas Medical Center, and FORTITUDE trial investigator, will ...

chardan-capital-maintains-buy-on-avidity-biosciences-maintains-33-price-target
Chardan Capital Maintains Buy on Avidity B...
05/10/2024 14:10:44

Chardan Capital analyst Keay Nakae maintains Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $33 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)